X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (847) 847
bisoprolol - therapeutic use (539) 539
male (530) 530
adrenergic beta-antagonists - therapeutic use (524) 524
female (488) 488
middle aged (430) 430
bisoprolol (414) 414
aged (356) 356
index medicus (307) 307
heart failure - drug therapy (305) 305
cardiac & cardiovascular systems (287) 287
adult (267) 267
treatment outcome (227) 227
heart failure (220) 220
propanolamines - therapeutic use (200) 200
hypertension - drug therapy (195) 195
pharmacology & pharmacy (181) 181
carvedilol (167) 167
mortality (166) 166
antihypertensive agents - therapeutic use (143) 143
blood pressure - drug effects (141) 141
heart rate - drug effects (139) 139
carbazoles - therapeutic use (134) 134
double-blind method (130) 130
metoprolol (130) 130
hypertension (124) 124
bisoprolol - administration & dosage (120) 120
beta-blockers (119) 119
heart failure - physiopathology (119) 119
metoprolol - therapeutic use (112) 112
drug therapy, combination (108) 108
medicine, general & internal (103) 103
heart failure - mortality (101) 101
bisoprolol - pharmacology (95) 95
adrenergic beta-antagonists - administration & dosage (94) 94
time factors (93) 93
angiotensin-converting enzyme inhibitors - therapeutic use (87) 87
adrenergic beta-antagonists - adverse effects (86) 86
cardiac-insufficiency bisoprolol (85) 85
myocardial-infarction (85) 85
follow-up studies (84) 84
adrenergic beta-antagonists - pharmacology (81) 81
aged, 80 and over (77) 77
drug therapy (77) 77
prospective studies (77) 77
randomized controlled trials as topic (77) 77
risk factors (76) 76
hypertension - physiopathology (74) 74
bisoprolol - adverse effects (65) 65
medicine & public health (65) 65
chronic disease (64) 64
survival (62) 62
double-blind (60) 60
atenolol (59) 59
adrenergic beta-1 receptor antagonists - therapeutic use (58) 58
dose-response relationship, drug (58) 58
analysis (57) 57
beta-blocker (57) 57
morbidity (57) 57
clinical trials as topic (56) 56
peripheral vascular disease (56) 56
therapy (56) 56
cardiac patients (55) 55
animals (54) 54
heart rate (54) 54
care and treatment (52) 52
electrocardiography (52) 52
randomized-trial (51) 51
echocardiography (50) 50
cardiology (48) 48
left-ventricular dysfunction (48) 48
management (48) 48
prognosis (47) 47
ventricular function, left - drug effects (46) 46
dilated cardiomyopathy (45) 45
trial (45) 45
atenolol - therapeutic use (44) 44
cardiovascular (43) 43
heart failure - complications (43) 43
adolescent (42) 42
blood-pressure (42) 42
guidelines (42) 42
propanolamines - adverse effects (41) 41
quality of life (41) 41
retrospective studies (41) 41
drug administration schedule (40) 40
propanolamines - administration & dosage (40) 40
severity of illness index (40) 40
stroke volume - drug effects (40) 40
beta blockers (39) 39
nebivolol (38) 38
abridged index medicus (37) 37
acute myocardial-infarction (37) 37
merit-hf (37) 37
adrenergic beta blockers (36) 36
metaanalysis (36) 36
blockade (35) 35
disease (35) 35
diuretics - therapeutic use (35) 35
hemodynamics - drug effects (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (827) 827
Russian (46) 46
German (37) 37
French (21) 21
Spanish (10) 10
Japanese (7) 7
Chinese (5) 5
Czech (5) 5
Polish (5) 5
Hungarian (4) 4
Italian (4) 4
Portuguese (3) 3
Ukrainian (3) 3
Dutch (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | treatment | CARDIAC & CARDIOVASCULAR SYSTEMS | angiotensin receptor blockers | QUALITY-OF-CARE | hydralazine | eplerenone | isosorbide dinitrate | RANDOMIZED INTERVENTION TRIAL | beta-blockers | MEDICAL-TREATMENT | GENERAL-PRACTICE | digoxin | spironolactone | CONVERTING-ENZYME-INHIBITORS | clinical recommendations | CARDIAC-INSUFFICIENCY | pharmacology | NATIONAL-SURVEY | aldosterone antagonists | ELDERLY-PATIENTS | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2009, Volume 54, Issue 19, pp. 1747 - 1762
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers countermeasures aimed to restore cardiac output. These... 
adrenergic receptor | beta-blockers | heart failure | sympathomimetic inotropes | sympatholytics | sympathetic nervous system | CARDIAC-INSUFFICIENCY BISOPROLOL | OBSTRUCTIVE SLEEP-APNEA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | AUTONOMIC FUNCTION | RANDOMIZED CONTROLLED-TRIAL | DILATED CARDIOMYOPATHY | LEFT-VENTRICULAR DYSFUNCTION | BETA-BLOCKADE | POSITIVE AIRWAY PRESSURE | BETA-ADRENERGIC RECEPTOR | Receptors, Adrenergic, alpha-1 - metabolism | Sympathetic Nervous System - drug effects | Humans | Heart Failure - physiopathology | Adrenergic alpha-Antagonists - therapeutic use | Receptors, Adrenergic, beta-2 - drug effects | Sympathetic Nervous System - physiopathology | Sympatholytics - therapeutic use | Cardiotonic Agents - therapeutic use | Receptors, Adrenergic - genetics | Parasympathetic Nervous System - physiopathology | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Sympathomimetics - therapeutic use | Receptors, Adrenergic, alpha-1 - drug effects | Heart Failure - genetics | Heart Failure - metabolism | Receptors, Adrenergic, beta-2 - metabolism | Heart Failure - drug therapy | Polymorphism, Genetic | Randomized Controlled Trials as Topic | Parasympathetic Nervous System - drug effects | Exercise Tolerance | Renin-Angiotensin System - drug effects | Hemodynamics - drug effects | Proteins | Confidence intervals | Heart rate | Heart failure | Heart attacks | Rodents | Mortality | Hospitalization | Kinases | Beta blockers
Journal Article
Journal Article
Journal Article
Journal Article
Annals of Surgery, ISSN 0003-4932, 06/2009, Volume 249, Issue 6, pp. 921 - 926
Journal Article